TY - JOUR
T1 - Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
AU - Giotti, Bruno
AU - Dolasia, Komal
AU - Zhao, William
AU - Cai, Peiwen
AU - Sweeney, Robert
AU - Merritt, Elliot
AU - Kiner, Evgeny
AU - Kim, Grace S.
AU - Bhagwat, Atharva
AU - Nguyen, Thinh
AU - Hegde, Samarth
AU - Fitzgerald, Bailey G.
AU - Shroff, Sanjana
AU - Dawson, Travis
AU - Garcia-Barros, Monica
AU - Abdul-Ghafar, Jamshid
AU - Chen, Rachel
AU - Gnjatic, Sacha
AU - Soto, Alan
AU - Brody, Rachel
AU - Kim-Schulze, Seunghee
AU - Chen, Zhihong
AU - Beaumont, Kristin G.
AU - Merad, Miriam
AU - Flores, Raja M.
AU - Sebra, Robert P.
AU - Horowitz, Amir
AU - Marron, Thomas U.
AU - Tocheva, Anna
AU - Wolf, Andrea
AU - Tsankov, Alexander M.
N1 - Publisher Copyright:
© 2024 American Association for Cancer Research.
PY - 2024/11/1
Y1 - 2024/11/1
N2 - Immunotherapies have shown great promise in pleural mesothelioma (PM), yet most patients still do not achieve significant clinical response, highlighting the importance of improving the understanding of the tumor microenvironment (TME). Here, we utilized high-throughput, single-cell RNA sequencing (scRNA-seq) to de novo identify 54 expression programs and construct a comprehensive cellular catalog of the PM TME. We found four cancer-intrinsic programs associated with poor disease outcome and a novel fetal-like, endothelial cell population that likely responds to VEGF signaling and promotes angiogenesis. Across cellular compartments, we observe substantial difference in the TME associated with a cancer-intrinsic sarcomatoid sig-nature, including enrichment in fetal-like endothelial cells, CXCL9+ macrophages, and cytotoxic, exhausted, and regulatory T cells, which we validated using imaging and bulk deconvolution analyses on independent cohorts. Finally, we show, both computationally and experimentally, that NKG2A:HLA-E interaction between NK and tumor cells represents an important new therapeutic axis in PM, especially for epithelioid cases. Significance: This manuscript presents the first single-cell RNA sequencing atlas of PM tumor mi-croenvironment. Findings of translational relevance, validated experimentally and using independent bulk cohorts, include identification of gene programs predictive of survival, a fetal-like endothelial cell population, and NKG2A blockade as a promising new immunotherapeutic intervention in PM.
AB - Immunotherapies have shown great promise in pleural mesothelioma (PM), yet most patients still do not achieve significant clinical response, highlighting the importance of improving the understanding of the tumor microenvironment (TME). Here, we utilized high-throughput, single-cell RNA sequencing (scRNA-seq) to de novo identify 54 expression programs and construct a comprehensive cellular catalog of the PM TME. We found four cancer-intrinsic programs associated with poor disease outcome and a novel fetal-like, endothelial cell population that likely responds to VEGF signaling and promotes angiogenesis. Across cellular compartments, we observe substantial difference in the TME associated with a cancer-intrinsic sarcomatoid sig-nature, including enrichment in fetal-like endothelial cells, CXCL9+ macrophages, and cytotoxic, exhausted, and regulatory T cells, which we validated using imaging and bulk deconvolution analyses on independent cohorts. Finally, we show, both computationally and experimentally, that NKG2A:HLA-E interaction between NK and tumor cells represents an important new therapeutic axis in PM, especially for epithelioid cases. Significance: This manuscript presents the first single-cell RNA sequencing atlas of PM tumor mi-croenvironment. Findings of translational relevance, validated experimentally and using independent bulk cohorts, include identification of gene programs predictive of survival, a fetal-like endothelial cell population, and NKG2A blockade as a promising new immunotherapeutic intervention in PM.
UR - http://www.scopus.com/inward/record.url?scp=85208451033&partnerID=8YFLogxK
U2 - 10.1158/2159-8290.CD-23-0017
DO - 10.1158/2159-8290.CD-23-0017
M3 - Article
C2 - 38959428
AN - SCOPUS:85208451033
SN - 2159-8274
VL - 14
SP - 2262
EP - 2278
JO - Cancer Discovery
JF - Cancer Discovery
IS - 11
ER -